The results suggest that targeting c-Met signaling may attenuate cell proliferation induced by other growth factors such as IL-6, and may therefore represent a novel approach to cancer treatment also in cancers that at first sight seem independent of c-Met signaling. Here, IL6 is linked to cancer.